Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Treasury Shares (2019 - 2026)

Pliant Therapeutics has reported Treasury Shares over the past 8 years, most recently at $557456.0 for Q1 2026.

  • Quarterly Treasury Shares fell 58.62% to $557456.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $557456.0 through Mar 2026, down 58.62% year-over-year, with the annual reading at $858247.0 for FY2025, 7.98% down from the prior year.
  • Treasury Shares was $557456.0 for Q1 2026 at Pliant Therapeutics, down from $858247.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.3 million in Q1 2025 and troughed at $6235.0 in Q1 2022.
  • The 5-year median for Treasury Shares is $941880.5 (2024), against an average of $846547.8.
  • Year-over-year, Treasury Shares tumbled 93.52% in 2022 and then surged 18641.56% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $354532.0 in 2022, then skyrocketed by 146.73% to $874748.0 in 2023, then increased by 6.62% to $932634.0 in 2024, then dropped by 7.98% to $858247.0 in 2025, then tumbled by 35.05% to $557456.0 in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Treasury Shares are $557456.0 (Q1 2026), $858247.0 (Q4 2025), and $1.0 million (Q3 2025).